Polar Capital Holdings Plc - ARCUTIS BIOTHERAPEUTICS INC ownership

ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 94 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.3%.

Quarter-by-quarter ownership
Polar Capital Holdings Plc ownership history of ARCUTIS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16,556,283
-44.5%
3,117,944
-0.3%
0.12%
-18.0%
Q2 2023$29,807,715
-13.6%
3,127,777
-0.2%
0.15%
-33.0%
Q1 2023$34,490,643
+16.2%
3,135,513
+56.3%
0.22%
-5.5%
Q4 2022$29,685,500
+18.6%
2,005,777
+53.2%
0.24%
+49.1%
Q3 2022$25,020,000
-16.5%
1,309,268
-6.9%
0.16%
-9.7%
Q2 2022$29,958,000
-12.8%
1,405,796
-21.2%
0.18%
+13.5%
Q1 2022$34,360,000
-7.1%
1,784,0050.0%0.16%
+11.5%
Q4 2021$37,000,000
-0.0%
1,784,005
+15.2%
0.14%
-7.9%
Q3 2021$37,003,000
-19.4%
1,548,901
-7.9%
0.15%
-24.1%
Q2 2021$45,917,000
+1.9%
1,682,543
+8.0%
0.20%
-28.7%
Q1 2021$45,060,000
+106.7%
1,557,543
+101.0%
0.28%
+111.4%
Q4 2020$21,801,000775,0000.13%
Other shareholders
ARCUTIS BIOTHERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 10,542,790$296,569,00022.84%
Bain Capital Life Sciences Investors, LLC 3,979,292$111,937,0007.03%
Pivotal bioVenture Partners Investment Advisor LLC 671,716$18,895,0006.23%
Omega Fund Management, LLC 640,199$18,009,0002.70%
Orbimed Advisors 6,073,850$170,857,0001.50%
Vivo Capital, LLC 867,170$24,393,0001.09%
Octagon Capital Advisors LP 100,000$2,813,0000.98%
Altium Capital Management LP 62,962$1,771,0000.66%
RA Capital Management 1,165,184$32,777,0000.46%
SILVERARC CAPITAL MANAGEMENT, LLC 8,505$239,0000.14%
View complete list of ARCUTIS BIOTHERAPEUTICS INC shareholders